Content by Texas Biomedical Research Institute
A live-attenuated vaccine under development is safe and 100 percent effective against Lassa virus in preclinical studies
| 3 min read
Research will assess the efficacy of surface coating and aerosolized decontamination technologies to combat SARS-CoV-2 and other respiratory pathogens on surfaces and in the air
| 3 min read
Animal models are a critical component of the biomedical pipeline necessary to fast-track drug and vaccine development
| 4 min read
Acute infections in male marmosets, a New World monkey, resemble the human illness the Zika virus creates in people
| 3 min read
Malaria researchers use new genomic tools to individualize parasite analysis.
| 2 min read
In the most extensive screen of its kind, Texas Biomed scientists have demonstrated the feasibility of repurposing already-approved drugs for use against highly pathogenic bacteria and viruses. The pathogens included emerging diseases and potential bioterror threats ranging from anthrax to the Marburg and Ebola viruses.
| 2 min read
Page 1 of 1 - 6 Total Items
